NCT06330441View on ClinicalTrials.gov

Pancreatic Cancer Screening in a Population at High Risk

NARecruitingINTERVENTIONAL
Enrollment

700

Participants

Timeline

Start Date

January 7, 2022

Primary Completion Date

December 31, 2025

Study Completion Date

January 6, 2028

Conditions
Pancreatic Ductal AdenocarcinomaHereditary DiseasesPancreatitis, Chronic
Interventions
PROCEDURE

endoscopic ultrasonography

endoscopic ultrasonography - frequency defined by arm

PROCEDURE

magnetic resonance

magnetic resonance - frequency defined by arm

DIAGNOSTIC_TEST

laboratory examination

hematology, biochemistry, Na+, K+, Cl-, Ca2+, bilirubin, ALT, AST, GGT, ALP, lactate dehydrogenase, creatinine, urea, fasting glycemia, HbA1c, alpha-amylase, LPS, albumin, total protein, CA19-9, CEA

Trial Locations (1)

65653

RECRUITING

Masaryk Memorial Cancer Institute, Brno

All Listed Sponsors
collaborator

Masaryk University

OTHER

lead

Masaryk Memorial Cancer Institute

OTHER